| Identification |
| Name: | 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aR)- |
| Synonyms: | 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)- (9CI);4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-,hydrochloride, (R)-;6ab-Aporphine-10,11-diol, hydrochloride (8CI);(-)-Apomorphine hydrochloride;Apomorphine hydrochloride;Apomorphinium chloride;NSC 11442;R-(-)-Apomorphinehydrochloride;Uprima; |
| CAS: | 314-19-2 |
| EINECS: | 206-243-0 |
| Molecular Formula: | C17H17 N O2 . Cl H |
| Molecular Weight: | 303.81 |
| InChI: | InChI=1/C17H17NO2.ClH/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;/h2-6,13,19-20H,7-9H2,1H3;1H |
| Molecular Structure: |
![(C17H17NO2.ClH) 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)- (9CI);4H-D...](https://img1.guidechem.com/chem/e/dict/0/314-19-2.jpg) |
| Properties |
| Transport: | 3249 |
| Melting Point: | 195 deg C (decomposes) |
| Flash Point: | 268.8°C |
| Boiling Point: | 473.4°Cat760mmHg |
| Density: | g/cm3 |
| Solubility: | Sol in alcohol, acetone, chloroform; slightly sol in water, benzene, ether, petroleum ether Slightly soluble in hydrochloric acid, ligand; soluble in ethanol, ethyl ether, acetone, benzene, chloroform, alkalies In water, 1.66X10+4 mg/L at 16 deg C |
| Specification: |
Apormorphine chloride (CAS NO.314-19-2) is also called (-)-Apomorphiniumhydrochloride ; (r)-id ; (theta)-id ; 11-diol,6-methyl-6a-beta-Noraporphine-1hydrochloride ; 6a-beta-Aporphine-10,11-diol,hydrochloride ; Apomorphinechloride . Apormorphine chloride (CAS NO.314-19-2) is high toxic. It is flammable. It will produce toxic fumes when buring. So the storage environment should be ventilate, low-temperature and dry. Keep Apormorphine chloride (CAS NO.314-19-2) separate from raw materials of food.
|
| Report: |
Reported in EPA TSCA Inventory.
|
| Packinggroup: | III |
| Biological Activity: | Prototypical dopamine agonist (pK i values are 6.43, 7.08, 7.59, 8.36 and 7.83 for human recombinant D 1 , D 2L , D 3 , D 4 and D 5 receptors respectively). Produces biphasic effects on locomotor activity, and displays anti-Parkinsonian and neuroprotective actions following systemic administration in vivo . |
| Flash Point: | 268.8°C |
| Color: | Hexagonal plates from chloroform+petroleum ether; rods from ether |
| Safety Data |
| |
 |